Population‐based study of autoimmune conditions and the risk of specific lymphoid malignancies
Lesley Anderson(Queen's University Belfast), Eric A. Engels(National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention), Ruth M. Pfeiffer(National Cancer Institute), Sonja I. Berndt(National Institutes of Health), Shahinaz M. Gadalla(Division of Cancer Epidemiology and Genetics), Ola Landgren(Cornell University), Joan L. Warren(Harvard University), Lindsay M. Morton(National Institutes of Health), Winnie Ricker(Information Management Services), Ruth Parsons(Information Management Services)
Cited by 260
Related Papers
Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.
|PubMed|2002|1.7k
2016 US lymphoid malignancy statistics by World Health Organization subtypes
|CA A Cancer Journal for Clinicians|2016|1.1k
Annual Report to the Nation on the Status of Cancer, 1975–2002, Featuring Population-Based Trends in Cancer Treatment
|JNCI Journal of the National Cancer Institute|2005|954